Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 4,000 shares of the stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of $92.93, for a total value of $371,720.00. Following the sale, the vice president now directly owns 96,100 shares in the company, valued at approximately $8,930,573. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of HQY stock opened at $92.46 on Monday. The firm has a market capitalization of $5.74 billion, a price-to-earnings ratio of 120.08, a price-to-earnings-growth ratio of 3.21 and a beta of 1.46. Healthequity Inc has a fifty-two week low of $42.92 and a fifty-two week high of $99.99.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 4th. The company reported $0.34 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.12. The firm had revenue of $71.10 million for the quarter, compared to the consensus estimate of $69.84 million. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The company’s revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.27 EPS. equities research analysts expect that Healthequity Inc will post 0.87 earnings per share for the current year.

A number of brokerages recently issued reports on HQY. KeyCorp increased their price target on Healthequity from $82.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, July 19th. SunTrust Banks increased their price target on Healthequity to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, September 5th. Zacks Investment Research raised Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, July 20th. Cantor Fitzgerald reissued a “hold” rating and set a $68.00 price target (up previously from $65.00) on shares of Healthequity in a research report on Monday, June 4th. Finally, Raymond James increased their price target on Healthequity from $85.00 to $105.00 and gave the stock an “outperform” rating in a research report on Monday, September 10th. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $93.08.

Several hedge funds have recently modified their holdings of HQY. Citigroup Inc. boosted its holdings in shares of Healthequity by 414.4% in the 1st quarter. Citigroup Inc. now owns 2,639 shares of the company’s stock valued at $160,000 after purchasing an additional 2,126 shares in the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Healthequity by 57.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock valued at $160,000 after purchasing an additional 779 shares in the last quarter. Rockefeller Capital Management L.P. acquired a new stake in shares of Healthequity in the 2nd quarter valued at $179,000. Cim LLC acquired a new stake in shares of Healthequity in the 2nd quarter valued at $204,000. Finally, S&CO Inc. acquired a new stake in shares of Healthequity in the 2nd quarter valued at $204,000. 96.94% of the stock is currently owned by hedge funds and other institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: What is a Leveraged Buyout (LBO)?

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.